Shanghai Pharmaceuticals Holding Co., Ltd Stock
Stocks
601607
CNE000000C82
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
2026-11-13
|
5-day change | 1st Jan Change | ||
| 16.13 CNY | -0.74% |
|
-3.76% | -9.69% |
| 11-04 | Shanghai Pharmaceuticals Gets China Clinical Trial Nod for Hypertension Inhalation Powder | MT |
| 11-04 | Shanghai Pharmaceuticals' Parent Raises Stake for 8.8 Million Yuan | MT |
| Market Cap | 53.49B 8.01B 7.26B 6.72B 6.06B 11.42B 756B 11.82B 80.69B 31.99B 404B 30.07B 29.43B 1,281B | P/E 2026 * |
11.1x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 55.96B 8.38B 7.6B 7.03B 6.34B 11.95B 790B 12.37B 84.4B 33.47B 422B 31.46B 30.79B 1,340B | EV / Sales 2026 * |
0.19x | EV / Sales 2027 * | 0.21x |
| Free-Float |
41.21% | Yield 2026 * |
2.79% | Yield 2027 * | 2.97% |
| 1 day | -0.74% | ||
| 1 week | -3.76% | ||
| Current month | -2.36% | ||
| 1 month | -3.41% | ||
| 3 months | -3.87% | ||
| 6 months | -5.40% | ||
| Current year | -9.69% |
| 1 week | 16.06 |  | 16.81 |
| 1 month | 16 | | 17.1 |
| Current year | 15.01 | | 18.13 |
| 1 year | 15.01 | | 18.35 |
| 3 years | 15.01 | | 23.2 |
| 5 years | 15.01 | | 28.64 |
| 10 years | 15.01 | | 29.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Dong Zhou
DFI | Director of Finance/CFO | 54 | 2026-06-24 |
Yong Zhong Li
PSD | President | 56 | 2023-06-28 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 2013-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 2016-06-27 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 2019-06-26 |
Ming Dong
BRD | Director/Board Member | 49 | 2023-06-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/18/24 | Other | Chairperson | 128,700 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.74% | -3.76% | -12.38% | -11.18% | 8.07B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,271B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 683B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 520B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 389B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 362B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 304B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 286B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 253B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.16% | +1.31% | +30.39% | +73.83% | 428B | |
| Weighted average by Cap. | +0.53% | +2.66% | +37.51% | +95.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 295B 44.25B 40.1B 37.09B 33.46B 63.06B 4,172B 65.28B 446B 177B 2,229B 166B 163B 7,074B | 314B 47.05B 42.64B 39.44B 35.58B 67.05B 4,436B 69.42B 474B 188B 2,370B 177B 173B 7,522B |
| Net income | 5.5B 824M 746M 690M 623M 1.17B 77.66B 1.22B 8.29B 3.29B 41.48B 3.09B 3.03B 132B | 5.8B 869M 788M 728M 657M 1.24B 81.95B 1.28B 8.75B 3.47B 43.77B 3.26B 3.19B 139B |
| Net Debt | 2.46B 369M 335M 309M 279M 526M 34.81B 545M 3.72B 1.47B 18.6B 1.39B 1.36B 59.03B | 12.26B 1.84B 1.66B 1.54B 1.39B 2.62B 173B 2.71B 18.49B 7.33B 92.52B 6.89B 6.75B 294B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | CN¥16.13 | -0.74% | 13,814,673 |
| 26-11-12 | CN¥16.25 | +0.25% | 13,420,396 |
| 26-11-11 | CN¥16.21 | -1.40% | 14,244,900 |
| 26-11-10 | CN¥16.44 | -0.60% | 9,973,214 |
| 26-11-09 | CN¥16.54 | -1.31% | 11,164,280 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 601607 Stock
Select your edition
All financial news and data tailored to specific country editions
